9/30/2025
The US Federal Trade Commission (FTC) has made determinations regarding high purity dissolving pulp imports from Brazil and Norway, addressing concerns over potential anticompetitive practices.
9/30/2025
The FDA has released a draft guidance for industry on E20 Adaptive Designs for Clinical Trials, developed under the ICH, to provide transparent and harmonized recommendations for adaptive clinical trials.
9/30/2025
Groff NA Hemplex LLC has submitted an application to the authorities to be registered as an importer of controlled substances, a move that could impact the pharmaceutical industry.
9/30/2025
The Bureau of Justice Statistics, part of the Department of Justice, is requesting OMB review and approval for a paperwork reduction act information collection, which includes the National Prisoner Statistics Program, with proposed changes.
9/30/2025
Denise Henderson, M.D. has made a decision and order, but no further details are available.
9/30/2025
FDA Commissioner has made a decision and order regarding a medical professional, Dr. David Payne, following a review of his medical practice
9/30/2025
The U.S. Federal Trade Commission has approved Pfizer's acquisition of BioNTech, following a review of the proposed transaction, which is expected to close in the first half of 2024, subject to customary closing conditions
9/30/2025
A healthcare professional, Jody Adams, has made a decision regarding a medical practice. The details of the decision are outlined in a formal order.
9/30/2025
The US Department of Agriculture has amended the National Poultry Improvement Plan (NPIP) regulations, aligning them with current producer practices and clarifying existing provisions, following approval by NPIP voting delegates at the 2022 National Plan Conference.
9/30/2025
The U.S. Department of State has renewed the charter for the President's Emergency Plan for AIDS Relief (PEPFAR) Scientific Advisory Board, a committee established to provide scientific advice on the administration of PEPFAR, under the authority granted by the Federal Advisory Committee Act
9/30/2025
The US government has announced the importation of culturally significant Korean objects for temporary exhibitions at the Arthur M. Sackler Gallery and The Art Institute of Chicago, citing national interest.
9/30/2025
The U.S. Department of Commerce has determined that thermoformed molded fiber products from Vietnam are being sold in the United States at a price lower than their true market value, and the investigation period was from April 1, 2024, to September 30, 2024.
9/30/2025
The U.S. Department of Commerce has determined that thermoformed molded fiber products from China are being sold in the U.S. at less than fair value from April 1, 2025, to September 30, 2025, and may lead to anti-dumping duties.
9/30/2025
The U.S. Department of Commerce has found that producers and exporters of molded fiber products from China are receiving subsidies, affecting trade between the two countries, with the investigation period spanning from January 1, 2023, to December 31, 2023.
9/30/2025
The U.S. Department of Commerce has determined that subsidies are being provided to Vietnamese producers and exporters of molded fiber products from January 1, 2023, to December 31, 2023, warranting countervailing duties.
9/30/2025
The National Marine Fisheries Service (NMFS) is seeking public comments on a proposal to issue an incidental harassment authorization for the Ketchikan Berth IV Expansion Project in Ketchikan, Alaska, which could allow the Ketchikan Dock Company, LLC to incidentally take marine mammals during construction work.
9/30/2025
The U.S. Department of Commerce has determined that silicon metal from Angola is being sold in the U.S. at a price lower than what is considered fair, and is seeking public comment on this finding, which covers the period from April 1, 2024, to March 30, 2025.
9/30/2025
The U.S. Department of Commerce has determined that silicon metal imports from Laos are likely being sold in the U.S. at below-market prices, prompting a request for public comment on the preliminary finding.
9/30/2025
The Bureau of Industry and Security has rescinded its interim final rule imposing new export license requirements for firearms and related components, citing public comments and the need to reduce regulatory burdens on industry and law-abiding firearms owners.
9/30/2025
The Bureau of Industry and Security (BIS) has issued an interim final rule (IFR) to expand end-user controls to cover affiliates of certain listed entities, aiming to address diversion concerns. The new rule applies restrictions to entities at least 50 percent owned by listed military end users or sanctioned parties, marking a significant improvement over the current standard.
9/30/2025
The National Marine Fisheries Service (NMFS) is soliciting public comments on a proposal to issue an incidental harassment authorization for the Yakutat Small Boat Harbor Replacement Project in Yakutat, Alaska, which could allow for the incidental taking of marine mammals during the project's activities.
9/30/2025
The U.S. Trade Representative has postponed the preliminary determination in the countervailing duty investigation into Indian freight rail couplers and parts, originally scheduled for October 2023
9/30/2025
The U.S. Department of Commerce has begun an administrative review of raw honey imports from Brazil, finding that two Brazilian companies sold honey at below-market prices, and is now rescinding the review for other companies that did not meet the review requirements
9/30/2025
The U.S. Court of International Trade has ruled in favor of the U.S. Department of Commerce's decision on antidumping duties for multilayered wood flooring from China, but the ruling does not align with Commerce's final results, prompting an amendment to the dumping margin for one company.
9/30/2025
The US Department of Commerce has postponed its preliminary determination in the countervailing duty investigation into unwrought palladium imports from the Russian Federation, allowing for further review of the case.
9/30/2025
The Commerce Department is reviewing antidumping and countervailing duty orders on Chinese solar cells, following a request from Nextracker LLC, and invites comments on preliminary results.
9/30/2025
The US Department of Commerce has aligned its final countervailing duty determination with its final less-than-fair-value determinations for imports of silicon metal from Thailand, in accordance with the terms of the agreement
9/30/2025
The Financial Crimes Enforcement Network (FinCEN) is seeking public comment on a proposed information collection to survey the costs of Anti-Money Laundering and Countering the Financing of Terrorism (AML/CFT) compliance for non-bank financial institutions. The proposed survey aims to gather data on the direct compliance costs incurred by these institutions with AML/CFT requirements.
9/30/2025
The Department of the Treasury is seeking public comments on the renewal of mandatory Treasury International Capital (TIC) Forms BC, BL-1, BL-2, BQ-1, BQ-2, and BQ-3, as part of its effort to reduce paperwork burdens.
9/30/2025
The Department of the Treasury is seeking public comments on the renewal of Treasury International Capital (TIC) Forms CQ-1 and CQ-2, which are used to report financial and commercial liabilities to unaffiliated foreign residents, as part of its effort to reduce paperwork burdens.
9/30/2025
FinCEN is seeking public comment on the proposed renewal of existing regulations requiring financial institutions to share information with government agencies and financial institutions, aimed at reducing paperwork and respondent burden
9/30/2025
The proposed regulations regarding previously taxed earnings and profits of foreign corporations and related basis adjustments have had a public hearing cancelled, effectively putting the plans on hold.
9/30/2025
The U.S. Department of Housing and Urban Development (HUD) has released final regulations outlining recordkeeping and reporting requirements for the average income test, which determines eligibility for low-income housing credits in residential rental projects.
9/30/2025
The IRS has withdrawn two notices of proposed rulemaking, including regulations on nonrecognition of gain or loss in corporate separations and multi-year tax reporting requirements for corporate separations and related transactions.
9/30/2025
The IRS has released interim final regulations reducing the PTIN user fee from $11 to $10, affecting individuals who apply or renew a PTIN, and aligning with the Independent Offices Appropriation Act of 1952, which authorizes user fee charging.
9/30/2025
The IRS and Treasury Department have updated the regulations to lower the user fee for tax return preparers to apply for or renew a PTIN from $11 to $10, effective immediately.
9/30/2025
The U.S. Small Business Administration (SBA) is updating its Development Company Loan Program by increasing the job creation or retention requirements for 504 Loan Projects and portfolio averages for Certified Development Companies.
9/30/2025
The Commodity Futures Trading Commission is proposing changes to its rules for swap dealers and major swap participants, allowing for exceptions to documentation requirements for certain swaps that are cleared or subject to prime broker arrangements.
9/29/2025
The US Nuclear Regulatory Commission is considering a partial site release of property at the Crystal River Nuclear Power Station, Unit 3, under License No. DPR-72, issued in December 1976.
9/29/2025
The U.S. Nuclear Regulatory Commission (NRC) and the State of Connecticut have signed an agreement allowing the state to assume regulatory authority over certain nuclear materials, effective September 25, 2025. The NRC will discontinue its regulatory authority over these materials, which include byproduct materials, source materials, and special nuclear materials in quantities not sufficient to form a critical mass.
9/29/2025
The U.S. Nuclear Regulatory Commission is evaluating DISA Technologies' request to operate its HPSA technology at abandoned uranium mine sites, pending additional safety and environmental information.
9/29/2025
The U.S. Energy Information Administration (EIA) is seeking public comment on a proposed three-year extension to the Petroleum Supply Reporting System (PSRS), with changes, as required by the Paperwork Reduction Act of 1995.
9/29/2025
The National Highway Traffic Safety Administration (NHTSA) has reopened the comment period for HOLON U.S. Inc.'s application to temporarily exempt vehicles equipped with automated driving systems (ADS) from certain Federal Motor Vehicle Safety Standards (FMVSS).
9/29/2025
The US Food and Drug Administration (FDA) has published a notice determining the regulatory review period for the DIAMONDBACK 360 Coronary Orbital Atherectomy Device patent extension, following a submission to the US Patent and Trademark Office (USPTO).
9/29/2025
The US Food and Drug Administration (FDA) has published a notice determining the regulatory review period for patent extension of medical device TRICLIP, following submissions to the US Patent and Trademark Office (USPTO).
9/29/2025
The FDA has published a notice determining the regulatory review period for MIPLYFFA, a human drug product, following a patent extension application submitted to the USPTO.
9/29/2025
The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995, related to establishing that a tobacco product was commercially marketed in the United States.
9/29/2025
The FDA has published a notice determining the regulatory review period for NIKTIMVO, a human biological product, following submissions to the USPTO for patent extension.
9/29/2025
The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995, aimed at protecting food against intentional adulteration.
9/29/2025
The FDA has determined that SEMPREX-D capsules, 8mg and 60mg, were not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of acrivastine and pseudoephedrine hydrochloride capsules.